Skip to Main Content

Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the body to try to cure an inherited form of blindness.

People with the disease have normal eyes but lack a gene that converts light into signals to the brain that enable sight.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.